Signal #150045 · SEC 8-K

$CSTL SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $CSTL filing catalyst

Why did $CSTL trigger an AI stock catalyst alert?

$CSTL triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +4.5/10). Headline: Castle Biosciences Reports Q3 Revenue Growth of 24%, Raises FY26 Revenue Guidance. Key points: - Q3 2026 revenue rose 24% YoY to $102.9M, driven by a 47% volume jump in TissueCypher reports. - FY2026 revenue guidance raised to $385M-$395M (previously $365M-$375M). - Q3 GAAP net loss widened to -$4.1M (-$0.13 per share) vs. -$0.5M (-$0.02) in Q3 2025.

How did $CSTL stock react after the SEC filing?

After the SEC 8-K for $CSTL, observed market reaction: T0 price $34.20. Past moves do not guarantee future results.

Where can I get real-time $CSTL SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $CSTL via Telegram and the VIP Web Terminal from €10/month.

$CSTL

$CSTL – Castle Biosciences Reports Q3 Revenue Growth of 24%, Raises FY26 Revenue Guidance

CASTLE BIOSCIENCES INC

2026-11-05 00:00:00 UTC · SEC 8-K · All $CSTL

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+4.5 / 10)

Q3 2026 revenue rose 24% YoY to $102.9M, driven by a 47% volume jump in TissueCypher reports.
FY2026 revenue guidance raised to $385M-$395M (previously $365M-$375M).
Q3 GAAP net loss widened to -$4.1M (-$0.13 per share) vs. -$0.5M (-$0.02) in Q3 2025.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →